Latest Quarterly Reporting News

Regis Resources reported a strong cash and bullion increase of $198 million in the March 2026 quarter, lifting its balance to $1.128 billion despite gold production trailing FY26 guidance. The company continues to monitor fuel supply risks amid national uncertainties.

ImpediMed Limited has appointed Erik Anderson as its new CEO and Managing Director, effective 7 April 2026, aiming to boost commercial execution and revenue growth in the US market. Dr Parmjot Bains will remain as an advisor until 30 June 2026 to ensure a smooth leadership transition.

Ramelius Resources (ASX: RMS) reported gold production of 38,093 ounces for the March 2026 quarter, maintaining FY26 guidance at the midpoint. The company progressed key projects including early Never Never ore delivery and completed A$110.2 million in share buybacks.

Robex Resources Inc. has released its Q1 2026 production update, with Kiniero Gold Mine in Guinea producing 39,367 ounces of gold following commercial production commencement in February. The company’s cash and bullion holdings rose to US$255 million.

Capricorn Metals delivered 30,358 ounces of gold in Q3 FY26 at the Karlawinda Gold Project, aligning with its mine plan and progressing the Karlawinda Expansion Project with peak construction activity.

Temas Resources Corp has opted to reduce its financial reporting frequency, moving from quarterly to semi-annual reports under a Canadian Securities Exchange pilot program. This change aligns with its status as a venture issuer and reflects its ongoing focus on proprietary processing technology and mineral projects.

Terramin Australia has initiated site preparation at its Tala Hamza Zinc Project in Algeria following the resolution of land access issues, backed by a significant government land acquisition. This milestone signals a shift from delays to active development readiness for one of the world’s largest undeveloped zinc deposits.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

Resonance Health has received a $732,851 refund from the Australian Taxation Office, reflecting its FY2025 R&D tax incentive claim net of income tax payable. This cash inflow strengthens the company’s financial position ahead of its March quarterly report.

Northern Star Resources has revised its FY26 production outlook downward amid operational hurdles at KCGM and Jundee, while its mill expansion project remains on track for early FY27 commissioning.

TZ Limited has responded to ASX queries over the deferral of a A$2.75 million debt repayment, asserting the delay was already well disclosed and unlikely to impact its share price materially.

Polymetals Resources has begun mining high-grade silver ore at its Endeavor mine, revealing silver grades significantly above expectations and initiating a direct shipping ore trial to capitalise on newfound value.